Effect of the luteinising hormone surge on regulation of vascular endothelial growth factor and extracellular matrix-degrading proteinases and their inhibitors in bovine follicles

Reproduction, Fertility and Development

Volumn 20, Issue 2, 2008, Pages 258-268

  Berisha, Bajram ^a   Steffl, Martin ^b   Welter, Harald ^b   Kliem, Heike ^a   Meyer, Heinrich H D ^a   Schams, Dieter ^a   Amselgruber, Werner ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Matrix metalloproteinases; Plasminogen activator

Indexed keywords

GELATINASE A; GONADORELIN; INTERSTITIAL COLLAGENASE; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS LUTEUM; COW; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVULATION; PROTEIN LOCALIZATION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CATTLE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADOTROPIN-RELEASING HORMONE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; OVARIAN FOLLICLE; PLASMINOGEN ACTIVATORS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE;

EID: 38549169434     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/RD07125     Document Type: Article

References (55)

1. Alon, T., Hemo, I., Itin, A., Peer, J., Stone, J., and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028. doi:10.1038/NM1095-1024
2. Augustin, H. G. (1998). Antiangiogenic tumour therapy: will it work? Trends Pharmacol. Sci. 19, 216-222. doi:10.1016/S0165-6147(98) 01211-5
3. Bacharach, E., Itin, A., and Keshet, E. (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA 89, 10 686-10 690. doi:10.1073/PNAS.89.22.10686
4. Bakke, L. J., Dow, M. P., Cassar, C. A., Peters, M. W., Pursley, J. R., and Smith, G. W. (2002). Effect of the preovulatory gonadotropin surge on matrix metalloproteinase (MMP)-14, MMP-2, and tissue inhibitor of metalloproteinases-2 expression within bovine periovulatory follicular and luteal tissue. Biol. Reprod. 66, 1627-1634. doi:10.1095/BIOLREPROD66.6.1627
5. Bakke, L. J., Li, Q., Cassar, C. A., Dow, M. P., Pursley, J. R., and Smith, G. W. (2004). Gonadotropin surge-induced differential upregulation of collagenase-1 (MMP-1) and collagenase-3 (MMP-13) mRNA and protein in bovine preovulatory follicles. Biol. Reprod. 71, 605-612. doi:10.1095/BIOLREPROD.104.027185
6. Berisha, B. (2007). 'Local Regulation in the Bovine Ovary: Extracellular Matrix Degradation, Angiogenesis and Angiolysis.' (Sierke Verlag: Göttingen.)
7. Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., and Einspanier, R. (2000a). Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol. Reprod. 63, 1106-1114. doi:10.1095/BIOLREPROD63.4.1106
8. Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., and Einspanier, R. (2000b). Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J. Endocrinol. 167, 371-382. doi:10.1677/JOE.0.1670371
9. Berisha, B., Pfaffl, M. W., and Schams, D. (2002). Expression of estrogen and progesterone receptors in the bovine ovary during estrous cycle and pregnancy. Endocrine 17, 207-214. doi:10.1385/ENDO:17:3:207
10. Berisha, B., Steffl, M., Amselgruber, W., and Schams, D. (2006a). Changes in fibroblast growth factor 2 and its receptors in bovine follicles before and after GnRH application and after ovulation. Reproduction 131, 319-329. doi:10.1530/REP.1.00798
11. Berisha, B., Welter, H., Shimizu, T., Miyamoto, A., Meyer, H. H. D., and Schams, D. (2006b). Expression of fibroblast growth factor 1 (FGF1) and FGF7 in mature follicles during the periovulatory period after GnRH in the cow. J. Reprod. Dev. 52, 307-313. doi:10.1262/JRD.17077
12. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159. doi:10.1016/0003-2697(87)90021-2
13. Christenson, L. K., and Stouffer, R. L. (1997). Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J. Clin. Endocrinol. Metab. 82, 2135-2142. doi:10.1210/JC.82.7.2135
14. Colgin, D. C., and Murdoch, W. J. (1997). Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator. Anim. Reprod. Sci. 47, 197-204. doi:10.1016/S0378-4320(97)00011-0
15. Connolly, D. T. (1991). Vascular permeability factor: a unique regulator of blood vessel function. J. Cell. Biochem. 47, 219-223. doi:10.1002/JCB.240470306
16. Curry, T. E., Jr, and Osteen, K. G. (2003). The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24, 428-465. doi:10.1210/ER.2002- 0005
17. Curry, T. E., Jr, and Smith, M. F. (2006). Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin. Reprod. Med. 24, 228-241. doi:10.1055/S-2006-948552
18. Dow, M. P., Bakke, L. J., Cassar, C. A., Peters, M. W., Pursley, J. R., and Smith, G. W. (2002a). Gonadotrophin surge-induced upregulation of mRNA for plasminogen activator inhibitors 1 and 2 within bovine periovulatory follicular and luteal tissue. Reproduction 123, 711-719. doi:10.1530/REP.0.1230711
19. Dow, M. P., Bakke, L. J., Cassar, C. A., Peters, M. W., Pursley, J. R., and Smith, G. W. (2002b). Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biol. Reprod. 66, 1413-1421. doi:10.1095/BIOLREPROD66.5.1413
20. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
21. Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25. doi:10.1210/ER.18.1.4
22. Fibbi, G., Caldini, R., Chevanne, M., Pucci, M., Schiavone, N., Morbidelli, L., Parenti, A., Granger, H. J., Del Rosso, M., and Ziche, M. (1998). Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Lab. Invest. 78, 1109-1119.
23. Field, S. L., Khachigian, L. M., Sleigh, M. J., Yang, G., Vandermark, S. E., Hogg, P. J., and Chesterman, C. N. (1996). Extracellular matrix is a source of mitogenically active platelet-derived growth factor. J. Cell. Physiol. 168, 322-332. doi:10.1002/(SICI)1097-4652(199608)168:2〈322:: AIDJCP11〉3.0.CO;2-5
24. Gerdes, U., Gafvels, M., Bergh, A., and Cajander, S. (1992). Localized increases in ovarian vascular permeability and leucocyte accumulation after induced ovulation in rabbits. J. Reprod. Fertil. 95, 539-550.
25. Herbert, J. M., Lamarche, I., and Carmeliet, P. (1997). Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J. Biol. Chem. 272, 23 585-23 591. doi:10.1074/JBC.272.38.23585
26. Jo, M., and Curry, T. E., Jr (2004). Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary. Biol. Reprod. 71, 1796-1806. doi:10.1095/BIOLREPROD.104.031823
27. John, A., and Tuszynski, G. (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7, 14-23.
28. Kliem, H., Welter, H., Kraetzl, W. D., Steffl, M., Meyer, H. H. D., Schams, D., and Berisha, B. (2007). Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum. Reproduction 134, 535-547. doi:10.1530/REP-06-0172
29. Kolb, C., Mauch, S., Krawinkel, U., and Sedlacek, R. (1999). Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp. Cell Res. 250, 122-130. doi:10.1006/EXCR.1999.4493
30. Lamoreaux, W. J., Fitzgerald, M. E., Reiner, A., Hasty, K. A., and Charles, S. T. (1998). Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res. 55, 29-42. doi:10.1006/MVRE.1997.2056
31. Liu, K., Liu, Y. X., Hu, Z. Y., Zou, R. Y., Chen, Y. J., Mu, X. M., and Ny, T. (1997). Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Mol. Cell. Endocrinol. 133, 109-116. doi:10.1016/S0303-7207(97) 00152-4
32. Liu, K., Wahlberg, P., Hagglund, A. C., and Ny, T. (2003). Expression pattern and functional studies of matrix degrading proteases and their inhibitors in the mouse corpus luteum. Mol. Cell. Endocrinol. 205, 131-140. doi:10.1016/S0303-7207(03)00147-3
33. Liu, Y. X. (2004). Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Front. Biosci. 9, 3356-3373. doi:10.2741/1487
34. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 25, 402-408. doi:10.1006/METH.2001.1262
35. Lopes, F. L., Desmarais, J., Gevry, N. Y., Ledoux, S., and Murphy, B. D. (2003). Expression of vascular endothelial growth factor isoforms and receptors Flt-1 and KDR during the peri-implantation period in the mink, Mustela vison. Biol. Reprod. 68, 1926-1933. doi:10.1095/BIOLREPROD.102.013441
36. Partridge, C. R., and Hawker, J. R., Jr, Forough, R. (2000). Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J. Cell. Biochem. 78, 487-499. doi:10.1002/1097-4644(20000901)78:3〈487::AID-JCB13〉3.0.CO;2-Z
37. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906. doi:10.1016/0006-291X(91)91276-I
38. Pfaffl, M. W., Wittmann, S. L., Meyer, H. H. D., and Bruckmaier, R. M. (2003). Gene expression of immunologically important factors in blood cells, milk cells, and mammary tissue of cows. J. Dairy Sci. 86, 538-545.
39. Politis, I., Srikandakumar, A., Turner, J. D., Tsang, B. K., Ainsworth, L., and Downey, B. R. (1990). Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig. Biol. Reprod. 43, 636-642. doi:10.1095/BIOLREPROD43.4.636
40. Reich, R., Miskin, R., and Tsafriri, A. (1985). Follicular plasminogen activator: involvement in ovulation. Endocrinology 116, 516-521.
41. Sato, Y., Abe, M., Tanaka, K., Iwasaka, C., Oda, N., Kanno, S., Oikawa, M., Nakano, T., and Igarashi, T. (2000). Signal transduction and transcriptional regulation of angiogenesis. Adv. Exp. Med. Biol. 476, 109-115.
42. Savio, J. D., Keenan, L., Boland, M. P., and Roche, J. F. (1988). Pattern of growth of dominant follicles during the oestrous cycle of heifers. J. Reprod. Fertil. 83, 663-671.
43. Schams, D., Hofer, F., Schallenberger, E., Hartl, M., and Karg, H. (1974). Pattern of luteinizing hormone (LH) and follicle stimulating hormone (FSH) in bovine blood plasma after injection of a synthetic gonadotropin- releasing hormone (Gn-RH). Theriogenology 1, 137-151. doi:10.1016/0093-691X(74)90032-6
44. Schams, D., Schallenberger, E., Hoffmann, B., and Karg, H. (1977). The oestrous cycle of the cow: hormonal parameters and time relationships concerning oestrus, ovulation, and electrical resistance of the vaginal mucus. Acta Endocrinol. (Copenh.) 86, 180-192.
45. Schams, D., Kosmann, M., Berisha, B., Amselgruber, W. M., and Miyamoto, A. (2001). Stimulatory and synergistic effects of luteinising hormone and insulin like growth factor 1 on the secretion of vascular endothelial growth factor and progesterone of cultured bovine granulosa cells. Exp. Clin. Endocrinol. Diabetes 109, 155-162. doi:10.1055/S-2001-14839
46. Schams, D., Berisha, B., Kosmann, M., and Amselgruber, W. M. (2002). Expression and localization of IGF family members in bovine antral follicles during final growth and in luteal tissue during different stages of estrous cycle and pregnancy. Domest. Anim. Endocrinol. 22, 51-72. doi:10.1016/S0739-7240(01)00116-3
47. Schams, D., Berisha, B., Neuvians, T., Amselgruber, W., and Kraetzl, W. D. (2003). Real-time changes of the local vasoactive peptide systems (angiotensin, endothelin) in the bovine corpus luteum after induced luteal regression. Mol. Reprod. Dev. 65, 57-66. doi:10.1002/MRD.10257
48. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. (1993). Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12, 303-324. doi:10.1007/BF00665960
49. Smith, G. W., Juengel, J. L., Mclntush, E. W., Youngquist, R. S., Garverick, H. A., and Smith, M. F. (1996). Ontogenies of messenger RNA encoding tissue inhibitor of metalloproteinases 1 and 2 within bovine periovulatory follicles and luteal tissue. Domest. Anim. Endocrinol. 13, 151-160. doi:10.1016/0739-7240(95)00065-8
50. Stetler-Stevenson, W. G. (1999). Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237-1241.
51. Tischer, E., Gospodarowicz, D., Mitchell, R., Silva, M., Schilling, J., Lau, K., Crisp, T., Fiddes, J. C., and Abraham, J. A. (1989). Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun. 165, 1198-1206. doi:10.1016/0006-291X(89)92729-0
52. Unemori, E. N., Ferrara, N., Bauer, E. A., and Amento, E. P. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 153, 557-562. doi:10.1002/JCP.1041530317
53. Wang, H., and Keiser, J. A. (1998). Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ. Res. 83, 832-840.
54. Zeleznik, A. J., Schuler, H. M., and Reichert, L. E., Jr (1981). Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 109, 356-362.
55. Zhao, Y., and Luck, M. R. (1995). Gene expression and protein distribution of collagen, fibronectin and laminin in bovine follicles and corpora lutea. J. Reprod. Fertil. 104, 115-123.